Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund II - Biotechnology Sub-Fund

+ Add to Watchlist

CARBIOA:LX

35.45 EUR

As of 00:00:00 ET on 03/03/2015.

Snapshot for Carnegie Fund II - Biotechnology Sub-Fund (CARBIOA)

Year To Date: +13.22% 3-Month: +21.74% 3-Year: +44.39% 52-Week Range: 21.19 - 35.97
1-Month: +6.68% 1-Year: +41.69% 5-Year: +34.73% Beta vs CXBT: -

Mutual Fund Chart for CARBIOA

No chart data available.
  • CARBIOA:LX 35.89
  • 1M
  • 1Y
Interactive CARBIOA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARBIOA

Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.

Inception Date: 10-10-2000 Telephone: 352-40-40-30-1
Managers: ULF ARVIDSSON
Web Site: www.carnegieam.com

Fundamentals for CARBIOA

NAV (on 2015-03-03) 35.45
Assets (M) (on 2015-02-27) 34.66
Fund Leveraged N
Minimum Investment 15,000.00
Minimum Subsequent Investment -

Dividends for CARBIOA

No dividends reported

Fees & Expenses for CARBIOA

Front Load -
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.10

Top Fund Holdings for CARBIOA

Filing Date: 01/30/2015
Name Position Value % of Total
Celgene Corp 26,400 2,859,652 9.130%
Gilead Sciences Inc 27,500 2,558,349 8.168%
Biogen Idec Inc 7,000 2,413,505 7.705%
Vertex Pharmaceuticals Inc 19,900 2,031,359 6.485%
Alexion Pharmaceuticals Inc 12,100 1,970,544 6.291%
Salix Pharmaceuticals Ltd 12,400 1,493,275 4.767%
BioMarin Pharmaceutical Inc 16,800 1,473,027 4.703%
Auspex Pharmaceuticals Inc 27,000 1,441,098 4.601%
Cempra Inc 58,000 1,433,714 4.577%
Isis Pharmaceuticals Inc 22,100 1,371,504 4.379%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil